secwatch.observer — SEC 8-K summary
======================================

Issuer:     NEOGEN CORP (NEOG)
CIK:        0000711377
Form:       8-K
Filed at:   2022-04-21T23:59:59+00:00
Accession:  0001193125-22-113159
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Neogen appoints Doug Jones as COO; VP Genomics Marylinn Munson departs
----------------------------------------------------------------------

- Doug Jones named Chief Operating Officer, a newly created role overseeing worldwide revenues and operations.
- Dr. Jason Lilly assumes interim responsibility for North American genomics operations.
- Marylinn Munson, former Vice President of Genomics, has left the company.
- Jerome Hagedorn (VP North American Operations) and Dr. Lilly will report to Jones; Jones reports to CEO John Adent.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/711377/000119312522113159/0001193125-22-113159-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/711377/000119312522113159/d317850d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-113159

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer